ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 89 filers reported holding ANTARES PHARMA INC in Q1 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $100,000 | -38.3% | 50,000 | 0.0% | 0.00% | – |
Q3 2017 | $162,000 | +153.1% | 50,000 | +150.0% | 0.00% | – |
Q2 2017 | $64,000 | +12.3% | 20,000 | 0.0% | 0.00% | – |
Q1 2017 | $57,000 | +21.3% | 20,000 | 0.0% | 0.00% | – |
Q4 2016 | $47,000 | +38.2% | 20,000 | 0.0% | 0.00% | – |
Q3 2016 | $34,000 | +61.9% | 20,000 | 0.0% | 0.00% | – |
Q2 2016 | $21,000 | +23.5% | 20,000 | 0.0% | 0.00% | – |
Q1 2016 | $17,000 | -29.2% | 20,000 | 0.0% | 0.00% | – |
Q4 2015 | $24,000 | -29.4% | 20,000 | 0.0% | 0.00% | – |
Q3 2015 | $34,000 | -19.0% | 20,000 | 0.0% | 0.00% | – |
Q2 2015 | $42,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
Q1 2015 | $54,000 | +5.9% | 20,000 | 0.0% | 0.00% | – |
Q4 2014 | $51,000 | +37.8% | 20,000 | 0.0% | 0.00% | – |
Q3 2014 | $37,000 | -30.2% | 20,000 | 0.0% | 0.00% | – |
Q2 2014 | $53,000 | -24.3% | 20,000 | 0.0% | 0.00% | – |
Q1 2014 | $70,000 | -22.2% | 20,000 | 0.0% | 0.00% | – |
Q4 2013 | $90,000 | +11.1% | 20,000 | 0.0% | 0.00% | – |
Q3 2013 | $81,000 | -2.4% | 20,000 | 0.0% | 0.00% | – |
Q2 2013 | $83,000 | – | 20,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 1,671,956 | $5,384,000 | 3.43% |
ARMISTICE CAPITAL, LLC | 5,700,000 | $18,354,000 | 2.34% |
Rubric Capital Management LP | 3,188,600 | $10,267,000 | 2.12% |
Broadfin Capital, LLC | 4,803,528 | $15,467,000 | 1.88% |
THOMPSON DAVIS & CO., INC. | 192,734 | $621,000 | 1.00% |
Asymmetry Capital Management, L.P. | 199,655 | $643,000 | 0.76% |
Perceptive Advisors | 4,267,253 | $13,741,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 946,987 | $3,049,000 | 0.21% |
Brown Advisory Securities, LLC | 275,000 | $886,000 | 0.20% |
EAM Investors, LLC | 251,619 | $810,000 | 0.13% |